The FDA has given market approval to Restylane Lyft with lidocaine for cheek augmentation, an injectable gel that aims to increase volume and smooth facial wrinkles.
Innoture, the manufacturer of microchanneling skincare treatment line Radara, has confirmed that Church Pharmacy is now distributing the products.
The results of two studies conducted by pharmaceutical company Galderma (UK) Limited have demonstrated high patient satisfaction for the use of Azzalure (AbobotulinumtoxinA), its botulinum toxin type A product, in the glabellar complex.
Aesthetics reports on the highlights from the British Association of Cosmetic Nurses Autumn Conference
On May 14, pharmaceutical company Galderma (UK) Limited celebrated 10 years since Azzalure®(AbobotulinumtoxinA) was first approved in Europe for the treatment of glabellar lines.
The exclusive UK and Ireland distributor of IBSA Italia, HA-Derma, has expanded its team by recruiting two new members.
UK distributor of the ACCOR Cosmetic Corrector, The Smart Group has appointed two new employees to work on the ACCOR brand.
On June 17, more than 250 medical professionals tuned in to the second webinar hosted by Aesthetics and supported by Galderma UK.
Pharmaceutical company Galderma invited guests to a celebratory breakfast in the Duncan Room at the Charlotte Street Hotel for the 20th anniversary of Restylane.
Dermatology company Galderma has announced that its hyaluronic acid dermal filler Restylane Silk has received approval by the US Food and Drug Administration (FDA) for lip augmentation with the use of a small blunt tip cannula.